Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Supraglottic oxygen delivery through an endotracheal tube for ERCP under deep sedation

Official title: Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study

Run by Zhejiang University · NCT07051980 · Data updated 2026-11-12

This tests whether delivering oxygen just above the vocal cords through an endotracheal tube can prevent low oxygen levels in adults having ERCP with deep sedation.

More Pancreatitis trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorZhejiang University
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedJune 12, 2025
Main results expectedDecember 2, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 17, 2025
Trial IDNCT07051980 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with ASA I–III who are scheduled for a sedated ERCP expected to last ≤45 minutes and who do not have severe cardiac, renal, or pulmonary disease and have BMI ≤30 kg/m².

Probably not a fit

Patients with COPD or other chronic pulmonary disease requiring oxygen, BMI >30 kg/m², severe cardiac or renal dysfunction, pregnancy or breastfeeding, active upper respiratory infections or fever, or those currently in other clinical trials are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-stage Phase II feasibility and safety study conducted at a single tertiary center to test supraglottic oxygen delivery via an endotracheal tube during non-intubated ERCP performed under deep sedation. Adult patients (≥18 years) with ASA I–III scheduled for an ERCP expected to last ≤45 minutes will receive the supraglottic oxygen device during the procedure and be monitored for hypoxia and other adverse events. Key exclusions include significant cardiac or renal dysfunction, COPD or other chronic pulmonary disease requiring oxygen, BMI >30 kg/m², pregnancy or active upper respiratory infection. The protocol focuses on whether this airway adjunct reduces the incidence of desaturation and is safe and feasible in this setting.

Why it matters

Potential benefit: If successful, this could reduce episodes of hypoxia during ERCP under deep sedation and lower cardiopulmonary complications.

How similar studies have gone: High-flow nasal oxygen and nasopharyngeal oxygenation have shown benefit in reducing desaturation during sedation, but using supraglottic oxygen delivery via an endotracheal tube for non-intubated ERCP is a relatively novel approach with limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years;
* The ASA classification ranges from I to III.
* Patients have signed the informed consent form.
* Patients scheduled to undergo sedated ERCP examination;
* The estimated duration of the procedure does not exceed 45 minutes.

Exclusion Criteria:

* Severe cardiac dysfunction (\<4 METs);
* Severe renal insufficiency (requiring preoperative dialysis);
* Diagnosed chronic obstructive pulmonary disease (COPD) or other acute/chronic pulmonary diseases requiring long-term/intermittent oxygen therapy;
* Increased intracranial pressure;
* Upper respiratory tract infections (oral/nasal/pharyngeal);
* Fever (core temperature \>37.5°C);
* Confirmed pregnancy or current breastfeeding;
* Allergy to sedatives (e.g., propofol) or medical adhesives;
* BMI \>30 kg/m²;
* Current participation in other clinical trials;

Where it's running

  • The First Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.